TEMPE, Ariz. and SAN JUAN CAPISTRANO, Calif., July 28, 2017 /PRNewswire/ -- When Pinscriptive
Hepatitis C has been a significant cost challenge for payers, providers, and patients for the last several years, as new genome-specific treatments have dominated the market at costs often exceeding $80,000 per prescription. The Pinscriptive platform delivers three primary benefits for payers and providers in their quest to manage specialty drug spend while ensuring appropriate health outcomes:
There is tremendous pressure for healthcare providers and payers to manage costs for their patients. By 2021, specialty drug pricing will account for 42% of pharmacy revenues. Identifying which drugs are most effective for which patients (precision analytics for precision medicine), Pinscriptive can significantly reduce costs for providers and payers, while still delivering appropriate patient health outcomes. T-Systems provides a 'secure' cloud-based platform to support these analytics that allows healthcare IT departments to easily consume this capability.
"We are excited about the initial outcome from our POC with Pinscriptive. We see many opportunities to provide a solution for healthcare providers and payers who want to maintain patient quality and manage out-of-control specialty drug use and costs. We can deliver these savings from our secure cloud offering," said Jim Sabogal, Senior Director for Life Sciences and Healthcare at T-Systems North America.
Roni Amiel, CEO of Pinscriptive added, "Our focus on enabling precision medicine through advanced analytics for physicians and payers was a significant achievement in partnership with T-Systems. We aim to continue to disrupt the high value specialty drugs market with similar cost savings programs in other high-cost specialty therapeutic areas such as Rheumatoid Arthritis, Multiple Sclerosis, and Oncology."
About PinscriptivePinscriptive is a healthcare Applied Analytics technologycompany focused on better managing specialty drug use and cost for its payer, provider, and biopharmaceutical company customers. Our proprietary advanced analytics platform uses algorithms and machine learning to better manage specialty drug utilization, cost, and health outcomes. Pinscriptive allows its customers to customize its value-based healthcare algorithms to deliver better, more precise, prescription decisions for patients..
About T-SystemsWith a footprint in more than 20 countries, 46,000 employees, and external revenue in excess of 9 billion dollars (2015), T-Systems is one of the world's leading providers of information and communications technology (ICT). T-Systems offers a range of integrated solutions for business customers, including the secure operation of legacy systems and classic ICT services, the transformation to cloud-based services (including tailored infrastructure, platforms and software) as well as data analytics, the Internet of Things, machine-to-machine (M2M) communication and Industrial Internet. This is all made possible thanks to its global reach in fixed-network and mobile communications, its highly secure data centers, a comprehensive cloud ecosystem built around standardized platforms and global partnerships, and the ability to offer top levels of security.
More information:http://www.t-systems.com https://www.facebook.com/TSystemsNorthAmerica/
View original content:http://www.prnewswire.com/news-releases/significant-healthcare-cost-savings-using-genomics-and-real-world-evidence-analytics-from-pinscriptive-and-t-systems-300495834.html
Subscribe to our Free Newsletters!
Donating blood is a life-saving act. Consider increasing your iron intake before and after you ...
Exfoliative dermatitis or erythroderma is a skin condition where the skin becomes reddened and ...
Alström syndrome, a rare genetic disorder due to ALMS1 mutations, occurs in the first year of ...View All